Enterovirus infections of the central nervous system

Virology

Volumn 411, Issue 2, 2011, Pages 288-305

  Rhoades, Ross E ^a   Tabor Godwin, Jenna M ^a   Tsueng, Ginger ^a   Feuer, Ralph ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

CNS; Enteroviruses

Indexed keywords

ALPHA INTERFERON; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; COXSACKIEVIRUS VACCINE; DEAD BOX PROTEIN; DECAY ACCELERATING FACTOR; ENTEROVIRUS 71 VACCINE; ENTEROVIRUS VECTOR; IMMUNOGLOBULIN; IRES TRANS ACTING FACTOR; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 5; NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE; PLECONARIL; POLIOMYELITIS VACCINE; RETINOIC ACID INDUCIBLE PROTEIN I; RIBAVIRIN; RNA DIRECTED RNA POLYMERASE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 3; TRANS ACTING FACTOR; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS VECTOR;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIVIRAL RESISTANCE; APOPTOSIS; ASEPTIC MENINGITIS; AUTOPHAGY; BLOOD BRAIN BARRIER; CELL MIGRATION; CENTRAL NERVOUS SYSTEM INFECTION; COXSACKIE VIRUS INFECTION; DRUG CEREBROSPINAL FLUID LEVEL; ECHO VIRUS; ENCEPHALOMYELITIS; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; HIPPOCAMPUS; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INTERFERON INDUCTION; INTERNAL RIBOSOME ENTRY SITE; MEMORY DISORDER; MOLECULAR BIOLOGY; MURINE ENCEPHALOMYELITIS VIRUS; NEURAL STEM CELL; NONHUMAN; PARECHOVIRUS; PERSISTENT VIRUS INFECTION; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA INTERFERENCE; SUBACUTE SCLEROSING PANENCEPHALITIS; TRANSLATION INITIATION; VIRAL TROPISM; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS MORPHOLOGY; VIRUS MUTATION; VIRUS PATHOGENESIS; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; HUMANS;

ENTEROVIRUS;

EID: 79952073086     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.12.014     Document Type: Review

References (227)

1. Abzug M.J. Presentation, diagnosis, and management of enterovirus infections in neonates. Paediatr. Drugs 2004, 6:1-10.
2. Agin H., Apa H., Unalp A., Kayserili E. Acute disseminated encephalomyelitis associated with enteroviral infection. Neurosciences (Riyadh.) 2010, 15:46-48.
3. Agol V.I., Gmyl A.P. Viral security proteins: counteracting host defences. Nat. Rev. Microbiol. 2010, 8:867-878.
4. Ahn J., Jee Y., Seo I., Yoon S.Y., Kim D., Kim Y.K., Lee H. Primary neurons become less susceptible to coxsackievirus B5 following maturation: the correlation with the decreased level of CAR expression on cell surface. J. Med. Virol. 2008, 80(3):434-440.
5. Alirezaei M., Kemball C.C., Flynn C.T., Wood M.R., Whitton J.L., Kiosses W.B. Short-term fasting induces profound neuronal autophagy. Autophagy 2010, 6(6):702-710.
6. Aliyari R., Ding S.W. RNA-based viral immunity initiated by the Dicer family of host immune receptors. Immunol. Rev. 2009, 227:176-188.
7. Baj A., Maccari G., Toniolo A. Detection of persistent polioviruses in patients with the post-polio syndrome. Formatex 2007, 859-867. edition. A. Méndez-Vilas (Ed.).
8. Barral P.M., Morrison J.M., Drahos J., Gupta P., Sarkar D., Fisher P.B., Racaniello V.R. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 2007, 81:3677-3684.
9. Barral P.M., Sarkar D., Fisher P.B., Racaniello V.R. RIG-I is cleaved during picornavirus infection. Virology 2009, 391:171-176.
10. Bergelson J.M. Intercellular junctional proteins as receptors and barriers to virus infection and spread. Cell Host Microbe 2009, 5:517-521.
11. Blomqvist S., Savolainen-Kopra C., Paananen A., El B.L., El Maamoon Nasr E.M., Firstova L., Zamiatina N., Kutateladze T., Roivainen M. Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1. Virus Res. 2010, 151(2):246-251.
12. Boussadia O., Niepmann M., Creancier L., Prats A.C., Dautry F., Jacquemin-Sablon H. Unr is required in vivo for efficient initiation of translation from the internal ribosome entry sites of both rhinovirus and poliovirus. J. Virol. 2003, 77:3353-3359.
13. Brahic M., Bureau J.F., Michiels T. The genetics of the persistent infection and demyelinating disease caused by Theiler's virus. Annu. Rev. Microbiol. 2005, 59(279-98):279-298.
14. Brandenburg B., Lee L.Y., Lakadamyali M., Rust M.J., Zhuang X., Hogle J.M. Imaging poliovirus entry in live cells. PLoS Biol. 2007, 5(7):e183.
15. Buenz E.J., Rodriguez M., Howe C.L. Disrupted spatial memory is a consequence of picornavirus infection. Neurobiol. Dis. 2006, 24:266-273.
16. Buenz E.J., Sauer B.M., Lafrance-Corey R.G., Deb C., Denic A., German C.L., Howe C.L. Apoptosis of hippocampal pyramidal neurons is virus independent in a mouse model of acute neurovirulent picornavirus infection. Am. J. Pathol. 2009, 175:668-684.
17. Cameron C.E., Suk O.H., Moustafa I.M. Expanding knowledge of P3 proteins in the poliovirus lifecycle. Future Microbiol. 2010, 5:867-881.
18. Campbell S.A., Mulvey M., Mohr I., Gromeier M. Attenuation of herpes simplex virus neurovirulence with picornavirus cis-acting genetic elements. J. Virol. 2007, 81(2):791-799.
19. Chang L.Y., Huang L.M., Gau S.S., Wu Y.Y., Hsia S.H., Fan T.Y., Lin K.L., Huang Y.C., Lu C.Y., Lin T.Y. Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med. 2007, 356:1226-1234.
20. Chapman N.M., Kim K.S. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr. Top. Microbiol. Immunol. 2008, 323:275-292.
21. Chen H.L., Huang J.Y., Chu T.W., Tsai T.C., Hung C.M., Lin C.C., Liu F.C., Wang L.C., Chen Y.J., Lin M.F., Chen C.M. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine 2008, 26:2882-2889.
22. Chen T.C., Weng K.F., Chang S.C., Lin J.Y., Huang P.N., Shih S.R. Development of antiviral agents for enteroviruses. J. Antimicrob. Chemother. 2008, 62:1169-1173.
23. Cheng M.F., Chen B.C., Huang T.S., Hsieh K.S., Chen S.N., Liu Y.C. Clinical application of reverse-transcription polymerase chain reaction and intravenous immunoglobulin for enterovirus encephalitis. Jpn J. Infect. Dis. 2008, 61:18-24.
24. Chung Y.C., Ho M.S., Wu J.C., Chen W.J., Huang J.H., Chou S.T., Hu Y.C. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 2008, 26:1855-1862.
25. Colbere-Garapin F., Duncan G., Pavio N., Pelletier I., Petit I. An approach to understanding the mechanisms of poliovirus persistence in infected cells of neural or non-neural origin. Clin. Diagn. Virol. 1998, 9:107-113.
26. Coleman J.R., Papamichail D., Skiena S., Futcher B., Wimmer E., Mueller S. Virus attenuation by genome-scale changes in codon pair bias. Science 2008, 320(5884):1784-1787.
27. Couderc T., Guivel-Benhassine F., Calaora V., Gosselin A.S., Blondel B. An ex vivo murine model to study poliovirus-induced apoptosis in nerve cells. J. Gen. Virol. 2002, 83:1925-1930.
28. Coyne C.B., Bergelson J.M. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 2006, 124(1):119-131.
29. Coyne C.B., Kim K.S., Bergelson J.M. Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2. EMBO J. 2007, 26(17):4016-4028.
30. Cree B.C., Bernardini G.L., Hays A.P., Lowe G. A fatal case of coxsackievirus B4 meningoencephalitis. Arch. Neurol. 2003, 60:107-112.
31. Crotty S., Andino R. Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin. Microbes Infect. 2002, 4:1301-1307.
32. Crotty S., Maag D., Arnold J.J., Zhong W., Lau J.Y., Hong Z., Andino R., Cameron C.E. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat. Med. 2000, 6:1375-1379.
33. Crotty S., Cameron C.E., Andino R. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. U. S. A 2001, 98:6895-6900.
34. Dalwai A., Ahmad S., Al-Nakib W. Echoviruses are a major cause of aseptic meningitis in infants and young children in Kuwait. Virol. J. 2010, 7(236):236.
35. Dan M., Chantler J.K. A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection. J. Virol. 2005, 79(14):9285-9295.
36. De M.J., Yaddanapudi K., Hornig M., Villar G., Serge R., Lipkin W.I. Induction of Toll-like receptor 3-mediated immunity during gestation inhibits cortical neurogenesis and causes behavioral disturbances. MBio. 2010, 1:e00176-10.
37. Deonarain R., Cerullo D., Fuse K., Liu P.P., Fish E.N. Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 2004, 110:3540-3543.
38. Desmond R.A., Accortt N.A., Talley L., Villano S.A., Soong S.J., Whitley R.J. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob. Agents Chemother. 2006, 50:2409-2414.
39. Dierssen U., Rehren F., Henke-Gendo C., Harste G., Heim A. Rapid routine detection of enterovirus RNA in cerebrospinal fluid by a one-step real-time RT-PCR assay. J. Clin. Virol. 2008, 42:58-64.
40. Doedens J.R., Kirkegaard K. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J. 1995, 14(5):894-907.
41. Domingo E., Martin V., Perales C., Escarmis C. Coxsackieviruses and quasispecies theory: evolution of enteroviruses. Curr. Top. Microbiol. Immunol. 2008, 323:3-32.
42. Dowdle W.R., De G.E., Kew O.M., Pallansch M.A., Wood D.J. Polio eradication: the OPV paradox. Rev. Med. Virol. 2003, 13:277-291.
43. Eberle K.E., Nguyen V.T., Freistadt M.S. Low levels of poliovirus replication in primary human monocytes: possible interactions with lymphocytes. Arch. Virol. 1995, 140(12):2135-2150.
44. Etchison D., Milburn S.C., Edery I., Sonenberg N., Hershey J.W. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J. Biol. Chem. 1982, 257(24):14806-14810.
45. Euscher E., Davis J., Holzman I., Nuovo G.J. Coxsackie virus infection of the placenta associated with neurodevelopmental delays in the newborn. Obstet. Gynecol. 2001, 98:1019-1026.
46. Feuer R., Whitton J.L. Preferential coxsackievirus replication in proliferating/activated cells: implications for virus tropism, persistence, and pathogenesis. Curr. Top. Microbiol. Immunol. 2008, 323(149-73):149-173.
47. Feuer R., Mena I., Pagarigan R., Slifka M.K., Whitton J.L. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J. Virol. 2002, 76:4430-4440.
48. Feuer R., Mena I., Pagarigan R.R., Harkins S., Hassett D.E., Whitton J.L. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am. J. Pathol. 2003, 163:1379-1393.
49. Feuer R., Pagarigan R.R., Harkins S., Liu F., Hunziker I.P., Whitton J.L. Coxsackievirus targets proliferating neuronal progenitor cells in the neonatal CNS. J. Neurosci. 2005, 25:2434-2444.
50. Feuer R., Ruller C.M., An N., Tabor-Godwin J.M., Rhoades R.E., Maciejewski S., Pagarigan R.R., Cornell C.T., Crocker S.J., Kiosses W.B., Pham-Mitchell N., Campbell I.L., Whitton J.L. Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period. J. Virol. 2009, 83:9356-9369.
51. Fitzgerald K.D., Semler B.L. Bridging IRES elements in mRNAs to the eukaryotic translation apparatus. Biochim. Biophys. Acta 2009, 1789:518-528.
52. Freistadt M.S., Eberle K.E. Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence. J. Virol. 1996, 70(9):6486-6492.
53. Freistadt M.S., Fleit H.B., Wimmer E. Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication. Virology 1993, 195(2):798-803.
54. Freistadt M.S., Vaccaro J.A., Eberle K.E. Biochemical characterization of the fidelity of poliovirus RNA-dependent RNA polymerase. Virol. J. 2007, 4:44.
55. Fujita K., Krishnakumar S.S., Franco D., Paul A.V., London E., Wimmer E. Membrane topography of the hydrophobic anchor sequence of poliovirus 3A and 3AB proteins and the functional effect of 3A/3AB membrane association upon RNA replication. Biochemistry 2007, 46(17):5185-5199.
56. Gamarnik A.V., Andino R. Switch from translation to RNA replication in a positive-stranded RNA virus. Genes Dev. 1998, 12(15):2293-2304.
57. Girard S., Couderc T., Destombes J., Thiesson D., Delpeyroux F., Blondel B. Poliovirus induces apoptosis in the mouse central nervous system. J. Virol. 1999, 73:6066-6072.
58. Gitlin L., Andino R. Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing. J. Virol. 2003, 77:7159-7165.
59. Gitlin L., Karelsky S., Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002, 418:430-434.
60. Goetz C., Everson R.G., Zhang L.C., Gromeier M. MAPK signal-integrating kinase controls cap-independent translation and cell type-specific cytotoxicity of an oncolytic poliovirus. Mol. Ther. 2010, 18:1937-1946.
61. Goodfellow I., Chaudhry Y., Richardson A., Meredith J., Almond J.W., Barclay W., Evans D.J. Identification of a cis-acting replication element within the poliovirus coding region. J. Virol. 2000, 74(10):4590-4600.
62. Gorbea C., Makar K.A., Pauschinger M., Pratt G., Bersola J.L., Varela J., David R.M., Banks L., Huang C.H., Li H., Schultheiss H.P., Towbin J.A., Vallejo J.G., Bowles N.E. A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J. Biol. Chem. 2010, 285:23208-23223.
63. Gromeier M., Wimmer E. Mechanism of injury-provoked poliomyelitis. J. Virol. 1998, 72:5056-5060.
64. Gromeier M., Lu H.H., Wimmer E. Mouse neuropathogenic poliovirus strains cause damage in the central nervous system distinct from poliomyelitis. Microb. Pathog. 1995, 18(4):253-267.
65. Gromeier M., Alexander L., Wimmer E. Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc. Natl Acad. Sci. USA 1996, 93(6):2370-2375. %19.
66. Gromeier M., Bossert B., Arita M., Nomoto A., Wimmer E. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J. Virol. 1999, 73(2):958-964.
67. Gromeier M., Solecki D., Patel D.D., Wimmer E. Expression of the human poliovirus receptor/CD155 gene during development of the central nervous system: implications for the pathogenesis of poliomyelitis. Virology 2000, 273(2):248-257.
68. Guest S., Pilipenko E., Sharma K., Chumakov K., Roos R.P. Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. J. Virol. 2004, 78(20):11097-11107.
69. Gupta S., Fernandez D., Siddiqui A., Tong W.C., Pohl K., Jungbluth H. Extensive white matter abnormalities associated with neonatal Parechovirus (HPeV) infection. Eur. J. Paediatr. Neurol. 2010, 14:531-534.
70. Haddad A., Nokhbeh M.R., Alexander D.A., Dawe S.J., Grise C., Gulzar N., Dimock K. Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70. J. Virol. 2004, 78(6):2674-2681.
71. Hagino-Yamagishi K., Nomoto A. In vitro construction of poliovirus defective interfering particles. J. Virol. 1989, 63(12):5386-5392.
72. Han J., Ma X.J., Wan J.F., Liu Y.H., Han Y.L., Chen C., Tian C., Gao C., Wang M., Dong X.P. Long persistence of EV71 specific nucleotides in respiratory and feces samples of the patients with Hand-Foot-Mouth Disease after recovery. BMC Infect. Dis. 2010, 10:178.
73. Harvala H., Simmonds P. Human parechoviruses: biology, epidemiology and clinical significance. J. Clin. Virol. 2009, 45:1-9.
74. Herold J., Andino R. Poliovirus RNA replication requires genome circularization through a protein-protein bridge. Mol. Cell 2001, 7(3):581-591.
75. Honda Y., Hosoya M., Ishii T., Shigeta S., Suzuki H. Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters. Antimicrob. Agents Chemother. 1994, 38:653-655.
76. Honda T., Saitoh H., Masuko M., Katagiri-Abe T., Tominaga K., Kozakai I., Kobayashi K., Kumanishi T., Watanabe Y.G., Odani S., Kuwano R. The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Brain Res. Mol. Brain Res. 2000, 77:19-28.
77. Hosking M.P., Lane T.E. The role of chemokines during viral infection of the CNS. PLoS Pathog. 2010, 6:e1000937.
78. Hosoya M., Shigeta S., Nakamura K., De C.E. Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro. Antivir. Res. 1989, 12:87-97.
79. Hosoya M., Shigeta S., Mori S., Tomoda A., Shiraishi S., Miike T., Suzuki H. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis. Antimicrob. Agents Chemother. 2001, 45:943-945.
80. Hotta Y., Honda T., Naito M., Kuwano R. Developmental distribution of coxsackie virus and adenovirus receptor localized in the nervous system. Brain Res. Dev. Brain Res. 2003, 143:1-13.
81. Huang M.C., Wang S.M., Hsu Y.W., Lin H.C., Chi C.Y., Liu C.C. Long-term cognitive and motor deficits after enterovirus 71 brainstem encephalitis in children. Pediatrics 2006, 118:e1785-e1788.
82. Huang S.C., Chang C.L., Wang P.S., Tsai Y., Liu H.S. Enterovirus 71-induced autophagy detected in vitro and in vivo promotes viral replication. J. Med. Virol. 2009, 81(7):1241-1252.
83. Hughes S.A., Thaker H.M., Racaniello V.R. Transgenic mouse model for echovirus myocarditis and paralysis. Proc. Natl. Acad. Sci. U. S. A 2003, 100:15906-15911.
84. Hunter P. Viral vigilance. New surveillance strategies and methods help to identify dangerous pathogens earlier: a prerequisite for efficient countermeasures. EMBO Rep. 2008, 9:948-950.
85. Hunziker I.P., Harkins S., Feuer R., Cornell C.T., Whitton J.L. Generation and analysis of an RNA vaccine that protects against coxsackievirus B3 challenge. Virology 2004, 330:196-208.
86. Hymas W.C., Aldous W.K., Taggart E.W., Stevenson J.B., Hillyard D.R. Description and validation of a novel real-time RT-PCR enterovirus assay. Clin. Chem. 2008, 54:406-413.
87. Ida-Hosonuma M., Iwasaki T., Yoshikawa T., Nagata N., Sato Y., Sata T., Yoneyama M., Fujita T., Taya C., Yonekawa H., Koike S. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 2005, 79:4460-4469.
88. Ireland D.D., Stohlman S.A., Hinton D.R., Kapil P., Silverman R.H., Atkinson R.A., Bergmann C.C. RNase L mediated protection from virus induced demyelination. PLoS Pathog. 2009, 5:e1000602.
89. Ishii T., Hosoya M., Mori S., Shigeta S., Suzuki H. Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis. Antimicrob. Agents Chemother. 1996, 40:241-243.
90. Jackson C.A., Cobbs C., Peduzzi J.D., Novak M., Morrow C.D. Repetitive intrathecal injections of poliovirus replicons result in gene expression in neurons of the central nervous system without pathogenesis. Hum. Gene Ther. 2001, 12(15):1827-1841.
91. Jackson W.T., Giddings T.H., Taylor M.P., Mulinyawe S., Rabinovitch M., Kopito R.R., Kirkegaard K. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol. 2005, 3(5):e156.
92. Jegouic S., Joffret M.L., Blanchard C., Riquet F.B., Perret C., Pelletier I., Colbere-Garapin F., Rakoto-Andrianarivelo M., Delpeyroux F. Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses. PLoS Pathog. 2009, 5(5):e1000412.
93. Jeulin H., Venard V., Carapito D., Finance C., Kedzierewicz F. Effective ribavirin concentration in mice brain using cyclodextrin as a drug carrier: evaluation in a measles encephalitis model. Antivir. Res. 2009, 81:261-266.
94. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., Yamaguchi O., Otsu K., Tsujimura T., Koh C.S., Reis e Sousa, Matsuura Y., Fujita T., Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
95. Kauder S.E., Racaniello V.R. Poliovirus tropism and attenuation are determined after internal ribosome entry. J. Clin. Invest. 2004, 113:1743-1753.
96. Kauder S., Kan S., Racaniello V.R. Age-dependent poliovirus replication in the mouse central nervous system is determined by internal ribosome entry site-mediated translation. J. Virol. 2006, 80:2589-2595.
97. Kemball C.C., Harkins S., Whitmire J.K., Flynn C.T., Feuer R., Whitton J.L. Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway. PLoS Pathog. 2009, 5:e1000618.
98. Kempf B.J., Barton D.J. Poliovirus 2A(Pro) increases viral mRNA and polysome stability coordinately in time with cleavage of eIF4G. J. Virol. 2008, 82(12):5847-5859.
99. Kim J.Y., Jeon E.S., Lim B.K., Kim S.M., Chung S.K., Kim J.M., Park S.I., Jo I., Nam J.H. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge. Vaccine 2005, 23:1672-1679.
100. Kim K.S., Tracy S., Tapprich W., Bailey J., Lee C.K., Kim K., Barry W.H., Chapman N.M. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA. J. Virol. 2005, 79:7024-7041.
101. Kim K.S., Chapman N.M., Tracy S. Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions. J. Virol. 2008, 82:2033-2037.
102. Kim Y.J., Yun S.H., Lim B.K., Park K.B., Na H.N., Jeong S.Y., Kim D.S., Cho Y.J., Jeon E.S., Nam J.H. Systemic analysis of a novel coxsackievirus gene delivery system in a mouse model. J. Microbiol. Biotechnol. 2009, 19(3):307-313.
103. Kitamura N., Semler B.L., Rothberg P.G., Larsen G.R., Adler C.J., Dorner A.J., Emini E.A., Hanecak R., Lee J.J., van der Werf S., Anderson C.W., Wimmer E. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature 1981, 291(5816):547-553.
104. Klingel K., Hohenadl C., Canu A., Albrecht M., Seemann M., Mall G., Kandolf R. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. U. S. A 1992, 89:314-318.
105. Kotla S., Peng T., Bumgarner R.E., Gustin K.E. Attenuation of the type I interferon response in cells infected with human rhinovirus. Virology 2008, 374:399-410.
106. Kung C.M., King C.C., Lee C.N., Huang L.M., Lee P.I., Kao C.L., Kung C.M., King C.C., Lee C.N., Huang L.M., Lee P.I., Kao C.L. Differences in replication capacity between enterovirus 71 isolates obtained from patients with encephalitis and those obtained from patients with herpangina in Taiwan. J. Med. Virol. 2007, 79:60-68.
107. Kuss S.K., Etheredge C.A., Pfeiffer J.K. Multiple host barriers restrict poliovirus trafficking in mice. PLoS Pathog. 2008, 4(6):e1000082.
108. Lancaster K.Z., Pfeiffer J.K. Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response. PLoS Pathog. 2010, 6(3):e1000791.
109. Lee T.C., Guo H.R., Su H.J., Yang Y.C., Chang H.L., Chen K.T. Diseases caused by enterovirus 71 infection. Pediatr. Infect. Dis. J. 2009, 28:904-910.
110. Lei X., Liu X., Ma Y., Sun Z., Yang Y., Jin Q., He B., Wang J. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 2010, 84:8051-8061.
111. Leland D.S., Ginocchio C.C. Role of cell culture for virus detection in the age of technology. Clin. Microbiol. Rev. 2007, 20:49-78.
112. Lewthwaite P., Perera D., How O.M., Last A., Kumar R., Desai A., Begum A., Ravi V., Shankar M.V., Hooi T.P., Cardosa M.J., Solomon T. Enterovirus 75 encephalitis in children, southern India. Emerg. Infect. Dis. 2010, 16:1780-1782.
113. Li Z.H., Li C.M., Ling P., Shen F.H., Chen S.H., Liu C.C., Yu C.K., Chen S.H. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J. Infect. Dis. 2008, 197:854-857.
114. Lin T.Y., Hsia S.H., Huang Y.C., Wu C.T., Chang L.Y. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin. Infect. Dis. 2003, 36:269-274.
115. Lin J.Y., Li M.L., Shih S.R. Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res. 2009, 37:47-59.
116. Lin Y.W., Chang K.C., Kao C.M., Chang S.P., Tung Y.Y., Chen S.H. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J. Virol. 2009, 83:6477-6483.
117. Lipton H.L., Kumar A.S., Trottier M. Theiler's virus persistence in the central nervous system of mice is associated with continuous viral replication and a difference in outcome of infection of infiltrating macrophages versus oligodendrocytes. Virus Res. 2005, 111:214-223.
118. Liu S.C., Lee P.I., Lee C.Y., Wang J.D., Chiang B.L., Chou M.C. Different cytokine levels in enterovirus meningitis and encephalitis. Infect. Dis. Clin. Pract. 2005, 13.
119. Madan V., Redondo N., Carrasco L. Cell permeabilization by poliovirus 2B viroporin triggers bystander permeabilization in neighbouring cells through a mechanism involving gap junctions. Cell. Microbiol. 2010, 12(8):1144-1157.
120. Malathi K., Dong B., Gale M., Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007, 448:816-819.
121. Marcotte L.L., Wass A.B., Gohara D.W., Pathak H.B., Arnold J.J., Filman D.J., Cameron C.E., Hogle J.M. Crystal structure of poliovirus 3CD protein: virally encoded protease and precursor to the RNA-dependent RNA polymerase. J. Virol. 2007, 81(7):3583-3596.
122. Matsumoto M., Seya T. TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv. Drug Deliv. Rev. 2008, 60:805-812.
123. Mena I., Perry C.M., Harkins S., Rodriguez F., Gebhard J., Whitton J.L. The role of B lymphocytes in coxsackievirus B3 infection. Am. J. Pathol. 1999, 155:1205-1215.
124. Merl S., Wessely R. Anti-coxsackieviral efficacy of RNA interference is highly dependent on genomic target selection and emergence of escape mutants. Oligonucleotides 2007, 17:44-53.
125. Merl S., Michaelis C., Jaschke B., Vorpahl M., Seidl S., Wessely R. Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice. Circulation 2005, 111:1583-1592.
126. Michos A.G., Syriopoulou V.P., Hadjichristodoulou C., Daikos G.L., Lagona E., Douridas P., Mostrou G., Theodoridou M. Aseptic meningitis in children: analysis of 506 cases. PLoS ONE 2007, 2:e674.
127. Minami K., Tsuda Y., Maeda H., Yanagawa T., Izumi G., Yoshikawa N. Acute transverse myelitis caused by Coxsackie virus B5 infection. J. Paediatr. Child Health 2004, 40:66-68.
128. Mirand A., Bailly J.L., Henquell C., Peigue-Lafeuille H. Rapid enterovirus genotyping in cerebrospinal fluids: a two-year prospective study in a virology laboratory setting. Pathol. Biol. Paris. 2008, 56:471-481.
129. Misbah S.A., Spickett G.P., Ryba P.C., Hockaday J.M., Kroll J.S., Sherwood C., Kurtz J.B., Moxon E.R., Chapel H.M. Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J. Clin. Immunol. 1992, 12:266-270.
130. MMWR Outbreaks following wild poliovirus importations - Europe, Africa, and Asia, January 2009-September 2010. MMWR Morb. Mortal. Wkly. Rep. 2010, 59:1393-1399.
131. Muir P., van Loon A.M. Enterovirus infections of the central nervous system. Intervirology 1997, 40:153-166.
132. Nagata N., Iwasaki T., Ami Y., Tano Y., Harashima A., Suzaki Y., Sato Y., Hasegawa H., Sata T., Miyamura T., Shimizu H. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J. Gen. Virol. 2004, 85:2981-2989.
133. Nathanson N. The pathogenesis of poliomyelitis: what we don't know. Adv. Virus Res. 2008, 71(1-50):1-50.
134. Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 2009, 15(7):794-797.
135. Noda S., Aguirre S.A., Bitmansour A., Brown J.M., Sparer T.E., Huang J., Mocarski E.S. Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood 2006, 107:30-38.
136. Novak J.E., Kirkegaard K. Improved method for detecting poliovirus negative strands used to demonstrate specificity of positive-strand encapsidation and the ratio of positive to negative strands in infected cells. J. Virol. 1991, 65(6):3384-3387.
137. Oberste M.S., Maher K., Pallansch M.A. Molecular phylogeny and proposed classification of the simian picornaviruses. J. Virol. 2002, 76:1244-1251.
138. Oh H.S., Pathak H.B., Goodfellow I.G., Arnold J.J., Cameron C.E. Insight into poliovirus genome replication and encapsidation obtained from studies of 3B-3C cleavage site mutants. J. Virol. 2009, 83(18):9370-9387.
139. Ohka S., Matsuda N., Tohyama K., Oda T., Morikawa M., Kuge S., Nomoto A. Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome. J. Virol. 2004, 78(13):7186-7198.
140. Ohka S., Sakai M., Bohnert S., Igarashi H., Deinhardt K., Schiavo G., Nomoto A. Receptor-dependent and -independent axonal retrograde transport of poliovirus in motor neurons. J. Virol. 2009, 83(10):4995-5004.
141. Oleszak E.L., Chang J.R., Friedman H., Katsetos C.D., Platsoucas C.D. Theiler's virus infection: a model for multiple sclerosis. Clin. Microbiol. Rev. 2004, 17:174-207.
142. Olson J.K., Ercolini A.M., Miller S.D. A virus-induced molecular mimicry model of multiple sclerosis. Curr. Top. Microbiol. Immunol. 2005, 296(39-53):39-53.
143. Ong K.C., Devi S., Cardosa M.J., Wong K.T. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J. Virol. 2010, 84:661-665.
144. Ooi M.H., Wong S.C., Lewthwaite P., Cardosa M.J., Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010, 9:1097-1105.
145. Ornoy A., Tenenbaum A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod. Toxicol. 2006, 21:446-457.
146. Papon L., Oteiza A., Imaizumi T., Kato H., Brocchi E., Lawson T.G., Akira S., Mechti N. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 2009, 393:311-318.
147. Park N., Katikaneni P., Skern T., Gustin K.E. Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J. Virol. 2008, 82:1647-1655.
148. Park J.H., Kim D.S., Cho Y.J., Kim Y.J., Jeong S.Y., Lee S.M., Cho S.J., Yun C.W., Jo I., Nam J.H. Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis. Vaccine 2009, 27:1974-1983.
149. Park N., Skern T., Gustin K.E. Specific cleavage of the nuclear pore complex protein Nup62 by a viral protease. J. Biol. Chem. 2010, 285:28796-28805.
150. Patel K.P., Coyne C.B., Bergelson J.M. Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells. J. Virol. 2009, 83(21):11064-11077.
151. Paul A.V., van Boom J.H., Filippov D., Wimmer E. Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Nature 1998, 393(6682):280-284.
152. Paul A.V., Peters J., Mugavero J., Yin J., van Boom J.H., Wimmer E. Biochemical and genetic studies of the VPg uridylylation reaction catalyzed by the RNA polymerase of poliovirus. J. Virol. 2003, 77(2):891-904.
153. Pedersen I.M., Cheng G., Wieland S., Volinia S., Croce C.M., Chisari F.V., David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007, 449:919-922.
154. Pelletier J., Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 1988, 334(6180):320-325.
155. Pelletier I., Saulnier A., Brisac C., Jegouic S., Vabret N., Tangy F., Blondel B., Colbere-Garapin F. Enhanced gene silencing in cells cured of persistent virus infection by RNA interference. J. Virol. 2010, 84:6880-6885.
156. Pevear D.C., Tull T.M., Seipel M.E., Groarke J.M. Activity of pleconaril against enteroviruses. Antimicrob. Agents Chemother. 1999, 43:2109-2115.
157. Pfeffer S., Sewer A., Lagos-Quintana M., Sheridan R., Sander C., Grasser F.A., van Dyk L.F., Ho C.K., Shuman S., Chien M., Russo J.J., Ju J., Randall G., Lindenbach B.D., Rice C.M., Simon V., Ho D.D., Zavolan M., Tuschl T. Identification of microRNAs of the herpesvirus family. Nat. Meth. 2005, 2:269-276.
158. Pfeiffer J.K. Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus. Adv. Virus Res. 2010, 77(85-118):85-118.
159. Pfeiffer J.K., Kirkegaard K. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc. Natl Acad. Sci. USA 2003, 100:7289-7294.
160. Pfeiffer J.K., Kirkegaard K. Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain. Proc. Natl Acad. Sci. USA 2006, 103(14):5520-5525.
161. Pilipenko E.V., Pestova T.V., Kolupaeva V.G., Khitrina E.V., Poperechnaya A.N., Agol V.I., Hellen C.U. A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev. 2000, 14:2028-2045.
162. Rahimi P., Tabatabaie H., Gouya M.M., Zahraie M., Mahmudi M., Ziaie A., Rad K.S., Shahmahmudi S., Musavi T., Azad T.M., Nategh R. Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran. J. Clin. Virol. 2007, 39(4):304-307.
163. Ramsingh A.I. CVB-induced pancreatitis and alterations in gene expression. Curr. Top. Microbiol. Immunol. 2008, 323(241-58):241-258.
164. Rantakallio P., Jones P., Moring J., Von W.L. Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. Int. J. Epidemiol. 1997, 26:837-843.
165. Ren R., Racaniello V.R. Poliovirus spreads from muscle to the central nervous system by neural pathways. J. Infect. Dis. 1992, 166(4):747-752.
166. Ricour C., Delhaye S., Hato S.V., Olenyik T.D., Michel B., van Kuppeveld F.J., Gustin K.E., Michiels T. Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein. J. Gen. Virol. 2009, 90:177-186.
167. Rodriguez M. Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis. Brain Pathol. 2007, 17:219-229.
168. Rodriguez M., Leibowitz J.L., Lampert P.W. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 1983, 13:426-433.
169. Romero J.R. Reverse-transcription polymerase chain reaction detection of the enteroviruses. Arch. Pathol. Lab. Med. 1999, 123:1161-1169.
170. Romero J.R. Pediatric group B coxsackievirus infections. Curr. Top. Microbiol. Immunol. 2008, 323(223-39):223-239.
171. Rotbart H.A. Diagnosis of enteroviral meningitis with the polymerase chain reaction. J. Pediatr. 1990, 117:85-89.
172. Roussarie J.P., Ruffie C., Brahic M. The role of myelin in Theiler's virus persistence in the central nervous system. PLoS Pathog. 2007, 3:e23.
173. Sabin A.B. Properties and behavior of orally administered attenuated poliovirus vaccine. J. Am. Med. Assoc. 1957, 164:1216-1223.
174. Salk J.E., Krech U., Youngner J.S., Bennett B.L., Lewis L.J., Bazeley P.L. Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines. Am. J. Public Health Nations Health 1954, 44:563-570.
175. Sawyer M.H. Enterovirus infections: diagnosis and treatment. Semin. Pediatr. Infect. Dis. 2002, 13:40-47.
176. Schein C.H., Oezguen N., van der Heden van Noort G.J., Filippov D.V., Paul A., Kumar E., Braun W. NMR solution structure of poliovirus uridylyated peptide linked to the genome (VPgpU). Peptides 2010, 31:1441-1448.
177. Schilthuizen C., Berenschot H.W., Levin M.D. Enteroviral encephalitis in a patient with a marginal zone lymphomatreated with rituximab. Neth. J. Med. 2010, 68:221-223.
178. Schmidtke M., Hammerschmidt E., Schuler S., Zell R., Birch-Hirschfeld E., Makarov V.A., Riabova O.B., Wutzler P. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment. J. Antimicrob. Chemother. 2005, 56:648-656.
179. Schmidtke M., Wutzler P., Zieger R., Riabova O.B., Makarov V.A. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3. Antivir. Res. 2009, 81:56-63.
180. Servais S., Caers J., Warling O., Frusch N., Baron F., De P.B., Beguin Y. Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma. Br. J. Haematol. 2010, 150:379-381.
181. Sharma R., Raychaudhuri S., Dasgupta A. Nuclear entry of poliovirus protease-polymerase precursor 3CD: implications for host cell transcription shut-off. Virology 2004, 320(2):195-205.
182. Shih S.R., Weng K.F., Stollar V., Li M.L. Viral protein synthesis is required for Enterovirus 71 to induce apoptosis in human glioblastoma cells. J. Neurovirol. 2008, 14(1):53-61.
183. Simonsen A., Cumming R.C., Brech A., Isakson P., Schubert D.R., Finley K.D. Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila. Autophagy 2008, 4(2):176-184.
184. Slifka M.K., Pagarigan R., Mena I., Feuer R., Whitton J.L. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J. Virol. 2001, 75:2377-2387.
185. Solomon T., Willison H. Infectious causes of acute flaccid paralysis. Curr. Opin. Infect. Dis. 2003, 16:375-381.
186. Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010, 10:778-790.
187. Steil B.P., Barton D.J. Cis-active RNA elements (CREs) and picornavirus RNA replication. Virus Res. 2009, 139(2):240-252.
188. Suhy D.A., Giddings T.H., Kirkegaard K. Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles. J. Virol. 2000, 74(19):8953-8965.
189. Suvisaari J., Mautemps N., Haukka J., Hovi T., Lonnqvist J. Childhood central nervous system viral infections and adult schizophrenia. Am. J. Psychiatry 2003, 160:1183-1185.
190. Tabor-Godwin J.M., Ruller C.M., Bagalso N., An N., Pagarigan R.R., Harkins S., Gilbert P.E., Kiosses W.B., Gude N.A., Cornell C.T., Doran K.S., Sussman M.A., Whitton J.L., Feuer R. A novel population of myeloid cells responding to coxsackievirus infection assists in the dissemination of virus within the neonatal CNS. J. Neurosci. 2010, 30:8676-8691.
191. Tam P.E., Messner R.P. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J. Virol. 1999, 73:10113-10121.
192. Tan E.L., Tan T.M., Tak K.C.V., Poh C.L. Inhibition of enterovirus 71 in virus-infected mice by RNA interference. Mol. Ther. 2007, 15:1931-1938.
193. Tan E.L., Wong A.P., Poh C.L. Development of potential antiviral strategy against coxsackievirus B4. Virus Res. 2010, 150:85-92.
194. Tapparel C., Junier T., Gerlach D., Van-Belle S., Turin L., Cordey S., Muhlemann K., Regamey N., Aubert J.D., Soccal P.M., Eigenmann P., Zdobnov E., Kaiser L. New respiratory enterovirus and recombinant rhinoviruses among circulating picornaviruses. Emerg. Infect. Dis. 2009, 15:719-726.
195. Tebruegge M., Curtis N. Enterovirus infections in neonates. Semin. Fetal Neonatal Med. 2009, 14:222-227.
196. Tung W.H., Lee I.T., Hsieh H.L., Yang C.M. EV71 induces COX-2 expression via c-Src/PDGFR/PI3K/Akt/p42/p44 MAPK/AP-1 and NF-kappaB in rat brain astrocytes. J. Cell. Physiol. 2010, 224:376-386.
197. Vaishnaw A.K., Gollob J., Gamba-Vitalo C., Hutabarat R., Sah D., Meyers R., de F.T., Maraganore J. A status report on RNAi therapeutics. Silence 2010, 1:14.
198. Venkatraman G., Behrens M., Pyrski M., Margolis F.L. Expression of Coxsackie-Adenovirus receptor (CAR) in the developing mouse olfactory system. J. Neurocytol. 2005, 34:295-305.
199. Verboon-Maciolek M.A., Groenendaal F., Hahn C.D., Hellmann J., van Loon A.M., Boivin G., de Vries L.S. Human parechovirus causes encephalitis with white matter injury in neonates. Ann. Neurol. 2008, 64:266-273.
200. Verboon-Maciolek M.A., Krediet T.G., Gerards L.J., de Vries L.S., Groenendaal F., van Loon A.M. Severe neonatal parechovirus infection and similarity with enterovirus infection. Pediatr. Infect. Dis. J. 2008, 27:241-245.
201. Victoria J.G., Kapoor A., Li L., Blinkova O., Slikas B., Wang C., Naeem A., Zaidi S., Delwart E. Metagenomic analyses of viruses in stool samples from children with acute flaccid paralysis. J. Virol. 2009, 83:4642-4651.
202. Vignuzzi M., Stone J.K., Arnold J.J., Cameron C.E., Andino R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 2006, 439:344-348.
203. Vignuzzi M., Wendt E., Andino R. Engineering attenuated virus vaccines by controlling replication fidelity. Nat. Med. 2008, 14(2):154-161.
204. Vogt D.A., Andino R. An RNA element at the 5'-end of the poliovirus genome functions as a general promoter for RNA synthesis. PLoS Pathog. 2010, 6(6):e1000936.
205. Volpe J.J. Neonatal encephalitis and white matter injury: more than just inflammation?. Ann. Neurol. 2008, 64:232-236.
206. Vuorinen T., Vainionpaa R., Vanharanta R., Hyypia T. Susceptibility of human bone marrow cells and hematopoietic cell lines to coxsackievirus B3 infection. J. Virol. 1996, 70(12):9018-9023.
207. Wahid R., Cannon M.J., Chow M. Dendritic cells and macrophages are productively infected by poliovirus. J. Virol. 2005, 79(1):401-409.
208. Ward C.D., Flanegan J.B. Determination of the poliovirus RNA polymerase error frequency at eight sites in the viral genome. J. Virol. 1992, 66(6):3784-3793.
209. Ward C.D., Stokes M.A., Flanegan J.B. Direct measurement of the poliovirus RNA polymerase error frequency in vitro. J. Virol. 1988, 62(2):558-562.
210. Webster A.D. Pleconaril - an advance in the treatment of enteroviral infection in immuno-compromised patients. J. Clin. Virol. 2005, 32:1-6.
211. Weng K.F., Li M.L., Hung C.T., Shih S.R. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 2009, 5(9):e1000593.
212. Werk D., Schubert S., Lindig V., Grunert H.P., Zeichhardt H., Erdmann V.A., Kurreck J. Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor. Biol. Chem. 2005, 386:857-863.
213. Whitton J.L., Cornell C.T., Feuer R. Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 2005, 3(10):765-776.
214. Wilkins C., Gale M. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 2010, 22:41-47.
215. Wimmer E., Mueller S., Tumpey T.M., Taubenberger J.K. Synthetic viruses: a new opportunity to understand and prevent viral disease. Nat. Biotechnol. 2009, 27:1163-1172.
216. Wong J., Zhang J., Si X., Gao G., Mao I., McManus B.M., Luo H. Autophagosome supports coxsackievirus B3 replication in host cells. J. Virol. 2008, 82(18):9143-9153.
217. Woodall C.J., Graham D.I. Evidence for neuronal localisation of enteroviral sequences in motor neurone disease/amyotrophic lateral sclerosis by in situ hybridization. Eur. J. Histochem. 2004, 48:129-134.
218. Woodall C.J., Riding M.H., Graham D.I., Clements G.B. Sequences specific for enterovirus detected in spinal cord from patients with motor neurone disease. BMJ 1994, 308:1541-1543.
219. Wu C.N., Lin Y.C., Fann C., Liao N.S., Shih S.R., Ho M.S. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 2001, 20:895-904.
220. Wu K.X., Ng M.M., Chu J.J. Developments towards antiviral therapies against enterovirus 71. Drug Discov. Today 2010, 15:1041-1051.
221. Xie J., Jiao Y., Qiu Z., Li Q., Li T. Significant elevation of B cells at the acute stage in enterovirus 71-infected children with central nervous system involvement. Scand. J. Infect. Dis. 2010.
222. Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 2009, 15(7):798-801.
223. Yang W.X., Terasaki T., Shiroki K., Ohka S., Aoki J., Tanabe S., Nomura T., Terada E., Sugiyama Y., Nomoto A. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology 1997, 229(2):421-428.
224. Yang B., Chuang H., Yang K.D. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol. J. 2009, 6:141.
225. Yoon S.Y., Ha Y.E., Choi J.E., Ahn J., Lee H., Kweon H.S., Lee J.Y., Kim D.H. Coxsackievirus B4 uses autophagy for replication after calpain activation in rat primary neurons. J. Virol. 2008, 82(23):11976-11978.
226. Yoshikawa T., Iwasaki T., Ida-Hosonuma M., Yoneyama M., Fujita T., Horie H., Miyazawa M., Abe S., Simizu B., Koike S. Role of the alpha/beta interferon response in the acquisition of susceptibility to poliovirus by kidney cells in culture. J. Virol. 2006, 80:4313-4325.
227. Yuan J., Cheung P.K., Zhang H.M., Chau D., Yang D. Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand. J. Virol. 2005, 79:2151-2159.